HOME > ARCHIVE
ARCHIVE
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
January 20, 2003
- New Year's Party Sees Great Expectations of Pharma Industry
January 20, 2003
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
January 20, 2003
- No More Room for Drug Marketing Deregulation: Mr Ishii of JPA
January 13, 2003
- WORLD NEWS IN BRIEF
January 13, 2003
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
January 13, 2003
- Sales of Novartis's Diovan Exceed \40 Billion
January 13, 2003
- PRESS SEMINAR
January 13, 2003
- Sankyo to Beef Up Marketing Force in Response to Mevalotin Patent Expiration
January 13, 2003
- The 23rd General Meeting of the Japanese Society of Clinical Pharmaceutical and Therapeutics (2)
January 13, 2003
- MPC Nearly Completes Reorganization of Marketing System
January 13, 2003
- Few Japanese Clinical Research Papers Quoted: JPMA Symposium
January 13, 2003
- Sword Enhances Meiji's Antibacterial Product Portfolio
January 13, 2003
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
January 13, 2003
- BUSINESS NEWS IN BRIEF
January 13, 2003
- OTC NEWS IN BRIEF
January 13, 2003
- CORPORATE ROUNDUP NEWS IN BRIEF
January 13, 2003
- MEDICAL DEVICE NEWS IN BRIEF
January 13, 2003
- Korosho to Get 3.8% Budget Increase in FY2003
January 13, 2003
- DIAGNOSTIC NEWS IN BRIEF
January 13, 2003
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
